Journal: Developmental biology

Article Title: Retinoic acid selectively regulates Fgf10 expression and maintains cell identity in the prospective lung field of the developing foregut.

doi: 10.1016/j.ydbio.2004.04.039

Figure Lengend Snippet: Fig. 4. Whole mount ISH of Fgfr2b and Fgf10 mRNA in vivo and in foregut cultures. (A) Fgfr2b mRNA is expressed throughout the foregut endoderm including the respiratory tract in E9.5 embryos and in (B) control cultures. (B, C) Fgfr2b expression is not disrupted by BMS treatment. (D) At E8.5, Fgf10 is expressed in the mesoderm of thyroid; subsequently (E9.5), signals appear in lung and thyroid domains. (E) In control cultures, these domains are preserved. (F) BMS treatment of explants younger than the 15-somite stage, but not older than that (G), prevents Fgf10 mRNA expression in the presumptive respiratory mesoderm (*). RA (106 M) has no obvious effects on Fgf10 expression. Area between dotted lines (in yellow) corresponds to the region of disrupted Fgf10 expression. Scale bars in A and E represent 85 and 150 Am, respectively.

Article Snippet: In some experiments, heparin beads soaked in human recombinant FGF10 (100 ng/Al, R&D Systems) or PBS (buffer) were grafted onto foreguts after 48 h culture.

Techniques: In Vivo, Control, Expressing

Journal: Developmental biology

Article Title: Retinoic acid selectively regulates Fgf10 expression and maintains cell identity in the prospective lung field of the developing foregut.

doi: 10.1016/j.ydbio.2004.04.039

Figure Lengend Snippet: Fig. 6. Exogenous FGF10 rescues lung budding and epithelial differentiation in BMS-treated cultures. PCNA staining in sagittal sections (A, D) and whole mount ISH of Ttf1 (B, E) and Sp-C (C, F) in 6-day cultures engrafted with heparin beads (human recombinant FGF10, PBS buffer). (A) FGF10 beads induced lung bud formation, local PCNA labeling and expression of Ttf1 (B) and Sp-C mRNA (C) in BMS-treated explants. PBS beads failed to induce a local increase in proliferation (D) and had no detectable Ttf1 (E) or Sp-C (F) signals in the respiratory region of foregut. Note the preserved Ttf1 staining in thyroid (B, E). (G–J) Quantitative analysis of PCNA- and TUNEL-stained sections from BMS-treated explants in the lung field. (H) Engraftment of an FGF10 bead results in a significant increase in the relative number of PCNA-labeled cells in the adjacent endoderm (G) as compared to a PBS bead. Mesodermal PCNA (G) or TUNEL labeling (I) in endoderm or mesoderm is not altered by FGF10. Graphs (H, J) represent mean and standard error; *P < 0.05. Lu, lung; Th, thyroid. Scale bar in E represents 240 Am.

Article Snippet: In some experiments, heparin beads soaked in human recombinant FGF10 (100 ng/Al, R&D Systems) or PBS (buffer) were grafted onto foreguts after 48 h culture.

Techniques: Staining, Recombinant, Labeling, Expressing, TUNEL Assay

Journal: Developmental biology

Article Title: Retinoic acid selectively regulates Fgf10 expression and maintains cell identity in the prospective lung field of the developing foregut.

doi: 10.1016/j.ydbio.2004.04.039

Figure Lengend Snippet: Fig. 7. Lung agenesis and disrupted expression of Ttf1 protein and Fgf10 mRNA in the respiratory region of foregut of vitamin A-deficient rats (A–D). H&E and Ttf1 immunostaining of transverse sections of control RAS foregut demonstrates (A) ongoing tracheoesophageal separation with Ttf1 expression restricted to the ventrally located tracheal epithelium and, more caudally, (B) primary lung bud epithelium intensely labeled with Ttf1. (C) In RAD foregut, the tube is irregularly shaped (*) and shows low levels of Ttf1 expression in the ventral endoderm at the prospective respiratory region that failed to bud. (D) Strong Ttf1 signals, however, are present in the thyroid bud. (E, F) Isotopic ISH of Fgf10 mRNA in transverse sections at the level of the lung buds in control RAS demonstrates localized signal in the mesoderm of the lung (F, enlarged), limb and urogenital tract (ug). In RAD (G, H), Fgf10 expression is preserved in the limb and urogenital tract but is disrupted in the presumptive lung field of the foregut (H, high magnification). Es, esophagus; fl, forelimb; hl, hindlimb; Lu, lung; Th, thyroid; Tr, trachea; RAD, RA deficient; RAS, RA sufficient; ug, urogenital ridge. Dashed boxes in E and G delineate close-up views in F and H, respectively. Arrowheads represent signals; asterisks indicate areas that failed to bud or to express Fgf10. Scale bars in B and G represent 80 and 480 Am, respectively.

Article Snippet: In some experiments, heparin beads soaked in human recombinant FGF10 (100 ng/Al, R&D Systems) or PBS (buffer) were grafted onto foreguts after 48 h culture.

Techniques: Expressing, Immunostaining, Control, Labeling

Journal: Developmental biology

Article Title: Retinoic acid selectively regulates Fgf10 expression and maintains cell identity in the prospective lung field of the developing foregut.

doi: 10.1016/j.ydbio.2004.04.039

Figure Lengend Snippet: Fig. 8. Proposed model for the role of RA in early lung morphogenesis. Early in mouse foregut organogenesis, RA signaling is active in all layers. (A) By the 15-somite stage, RA has induced proliferation of a critical mass of mesodermal cells in the lung field, while signaling in endoderm maintains identity in lung progenitor cells (in red). (B) At around 25 somites, the condensing mesodermal cells begin to locally express Fgf10 (in green), which then activates the Fgf pathway in the endoderm to expand the population of lung progenitor cells into a primary endodermal bud. (C) Once secondary buds form and branching morphogenesis starts, RA signaling is downregulated in the lung and Fgf10 expression becomes independent of RA.

Article Snippet: In some experiments, heparin beads soaked in human recombinant FGF10 (100 ng/Al, R&D Systems) or PBS (buffer) were grafted onto foreguts after 48 h culture.

Techniques: Expressing

Journal: Arteriosclerosis, Thrombosis, and Vascular Biology

Article Title: Trophoblast-Induced Changes in C-X-C Motif Chemokine 10 Expression Contribute to Vascular Smooth Muscle Cell Dedifferentiation During Spiral Artery Remodeling

doi: 10.1161/atvbaha.112.300354

Figure Lengend Snippet: Figure 2. C-X-C motif chemokine 10 (CXCL10), stanniocalcin-1, and placental growth factor mRNA expression is significantly increased by trophoblast conditioned media (CM). Messenger RNA expression in vascular spheroids was measured by quantitative real-time PCR after stimulation with trophoblast CM for 24 hours (n=4). Data are expressed as mRNA expression relative to an external calibrator. A, CXCL10. B, Stanniocalcin-1. C, Placental growth factor. All data are presented as mean±SEM. *P<0.05.

Article Snippet: CXCL10 recombinant protein was purchased from R & D Systems (Abingdon, UK).

Techniques: Expressing, RNA Expression, Real-time Polymerase Chain Reaction

Journal: Arteriosclerosis, Thrombosis, and Vascular Biology

Article Title: Trophoblast-Induced Changes in C-X-C Motif Chemokine 10 Expression Contribute to Vascular Smooth Muscle Cell Dedifferentiation During Spiral Artery Remodeling

doi: 10.1161/atvbaha.112.300354

Figure Lengend Snippet: Figure 3. C-X-C motif chemokine 10 (CXCL10) protein is expressed by vascular spheroids stimulated with trophoblast con- ditioned media. A, Vascular spheroid lysates were examined by Western blot analysis for the presence of CXCL10. Tubulin was used as an internal loading control. The image shown is represen- tative of 3 independent experiments. Densitometric analysis of Western blots (n=3) with mean±SEM CXCL10/tubulin presented as a fold-change over control-treated spheroids. *P<0.05. Vascu- lar spheroids treated with control media (B) or trophoblast condi- tioned media (C) were cryosectioned and sections were examined by immunostaining for the presence of CXCL10. Sections were taken through approximately the center of the spheroid. Negative control incubated with rabbit IgG in place of primary antibody is inset. Scale bar,100 µm.

Article Snippet: CXCL10 recombinant protein was purchased from R & D Systems (Abingdon, UK).

Techniques: Western Blot, Control, Immunostaining, Negative Control, Incubation

Journal: Arteriosclerosis, Thrombosis, and Vascular Biology

Article Title: Trophoblast-Induced Changes in C-X-C Motif Chemokine 10 Expression Contribute to Vascular Smooth Muscle Cell Dedifferentiation During Spiral Artery Remodeling

doi: 10.1161/atvbaha.112.300354

Figure Lengend Snippet: Figure 4. C-X-C motif chemokine 10 (CXCL10) protein is expressed by first trimester decidua and dissected spiral arteries stimulated with trophoblast conditioned media. CXCL10 (A and C) and α-smooth muscle actin protein (D) expression was examined by immunohis- tochemistry in serially sectioned first trimester decidua (n=5; representative image shown). CXCL10 and α-smooth muscle actin protein colocalized to the same cells (indicated by arrowheads). Trophoblasts (labeled with CK7, B) were present at this stage of remodeling. Negative control (inset) was incubated with nonimmune IgG in place of primary antibody. Scale bar represents 100 µm or 50 µm in zoom. (E) Expression of CXCL10 (green) and (F) VWF, an endothelial cell marker (red), was examined in a dissected spiral artery treated with extravillous trophoblast (EVT) conditioned media (G, merge). EC indicates endothelial cells; and VSM, vascular smooth muscle. Negative control (inset) was incubated with nonimmune IgG in place of primary antibody. Scale bar, 50 µm.

Article Snippet: CXCL10 recombinant protein was purchased from R & D Systems (Abingdon, UK).

Techniques: Expressing, Labeling, Negative Control, Incubation, Marker

Journal: Arteriosclerosis, Thrombosis, and Vascular Biology

Article Title: Trophoblast-Induced Changes in C-X-C Motif Chemokine 10 Expression Contribute to Vascular Smooth Muscle Cell Dedifferentiation During Spiral Artery Remodeling

doi: 10.1161/atvbaha.112.300354

Figure Lengend Snippet: Figure 5. The role of IFN-γ in C-X-C motif chemokine 10 (CXCL10) expression. A, Recombinant IFN-γ induces CXCL10 expression in vascular spheroids. Control or rhIFN-γ was added to spheroids made of endothelial cell (EC) alone, vascular smooth muscle cell (VSMC) alone, or cocultured EC/VSMC. CXCL10 expression was measured by Western blot analysis (n=4). B, Neutralizing IFN-γ in extravillous trophoblast (EVT) conditioned media (CM) decreased vascular spheroid CXCL10 expression. Control media or EVT CM was incubated with IFN-γ–neutralizing antibody or corresponding IgG control and added to EC/VSMC spheroids. CXCL10 expression was determined by Western blot analysis. *P<0.05 (n=5).

Article Snippet: CXCL10 recombinant protein was purchased from R & D Systems (Abingdon, UK).

Techniques: Expressing, Recombinant, Control, Western Blot, Incubation

Journal: Arteriosclerosis, Thrombosis, and Vascular Biology

Article Title: Trophoblast-Induced Changes in C-X-C Motif Chemokine 10 Expression Contribute to Vascular Smooth Muscle Cell Dedifferentiation During Spiral Artery Remodeling

doi: 10.1161/atvbaha.112.300354

Figure Lengend Snippet: Figure 6. The effects of extravillous tro- phoblast (EVT) conditioned media (CM) and C-X-C motif chemokine 10 (CXCL10) on vascular smooth muscle cells (VSMCs). VSMCs were incubated for 72 hours in media containing 0.5% FCS, then a further 72 hours with indicated concentrations of EVT CM and recombi- nant human CXCL10 (n=at least 5 inde- pendent experiments). Expression of (A) α-smooth muscle actin and (B) calponin was examined by Western blot analysis. Time-lapse microscopy was used to analyze the effects of rhCXCL10 (C) and EVT CM (D) on VSMC motility during a 24-hour incubation. Data are displayed as the mean±SEM of a minimum of 3 pooled experiments. *P<0.05; **P<0.01.

Article Snippet: CXCL10 recombinant protein was purchased from R & D Systems (Abingdon, UK).

Techniques: Incubation, Expressing, Western Blot, Time-lapse Microscopy

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Article Title: Homocysteine modulates CXCL10/CXCR3 axis activity to induce endothelial dysfunction.

doi: 10.14715/cmb/2024.70.2.28

Figure Lengend Snippet: Fig. 3. (A, B) qRT-PCR and Western blot analysis of CXCL10 and CXCR3 expression in HAECs treated with different concentrations of Hcy. (C) IHC analysis of the aorta in HHcy mice showing CXCL10 and CXCR3 expression. (D) qRT-PCR analysis of CXCL10 and CXCR3 expression in arterial endothelial cells.

Article Snippet: Additionally, HAECs were exposed to specific agents including Anti-CXCL10 antibodies (701225, Invitrogen, USA), Anti-CXCR3 antibodies (ab71864, Abcam, UK), IgG control antibodies (31154, Thermo Fisher, USA), NBI-74330 (a CXCR3 inhibitor, 4528, Tocris Bioscience, UK), and CXCL10 agonist (266-IP, R&D Systems, USA).

Techniques: Quantitative RT-PCR, Western Blot, Expressing